Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology company has $462.6 million in cash and equivalents, enough runway to fund ...
Both small and large companies trust LabVantage—the most flexible and commercially available informatics solution—across various industries to operate their laboratories. LabVantage’s platform helps ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results